You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Positive efficacy data for Sensorian’s candidate

Sensorion – a company which focuses on the development of novel therapies to treat hearing loss disorders – has reported further analysis from its proof-of-concept phase 2a clinical trial of SENS-401.